Quarterly Report • Nov 6, 2007
Quarterly Report
Open in ViewerOpens in native device viewer
| Vorwort Geschäftsverlauf Finanzbericht + + Nine-month Report 1 Januar y – 30 September 2007 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + |
||
|---|---|---|---|---|
| -- | -- | ------------------------------------------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
| in Euro million | Q3 2007 |
Q3 2006 |
Change | 9M 2007 |
9M 2006 |
Change |
|---|---|---|---|---|---|---|
| Sales and orders position |
||||||
| Order entry | 31.3 | 37.5 | -16.5% | 95.5 | 115.0 | -17.0% |
| Order backlog as of 09/30 |
- | - | - | 72.0 | 82.8 | -13.0% |
| Total sales | 22.3 | 31.3 | -28.8% | 98.7 | 113.5 | -13.0% |
| Sales margin | -23.6% | 4.3% | - | 0.2% | 10.0% | - |
| Gross profit | 9.2 | 14.0 | -34.3% | 43.2 | 52.5 | -17.7% |
| Gross margin | 41.4% | 44.7% | - | 43.8% | 46.2% | - |
| Costs of sales | 13.1 | 17.3 | -24.3% | 55.4 | 61.0 | -9.2% |
| EBITDA | -3.9 | 3.1 | -225.8% | 5.1 | 19.1 | -73.3% |
| EBITDA margin | -17.3% | 10.0% | 5.1% | 16.8% | - | |
| EBIT | -4.9 | 1.7 | -388.2% | 1.3 | 14.3 | -90.9% |
| EBIT margin | -21.8% | 5.4% | 1.3% | 12.6% | - | |
| Earnings after tax | -5.3 | 1.4 | -478.6% | 0.2 | 11.3 | -98.2% |
| Basic earnings per share |
-0.31 | 0.08 | -487.5% | 0.01 | 0.67 | -98.5% |
| Balance sheet | ||||||
| Shareholders' equity | - | - | - | 99.1 | 95.1 | 4.2% |
| Equity ratio | - | - | - | 68.1% | 61.1% | - |
| Return on equity | -5.3% | 1.4% | - | 0.2% | 11.9% | - |
| Balance sheet total | - | - | - | 145.6 | 155.7 | -6.5% |
| Net cash | - | - | - | 8.3 | 14.1 | -41.1% |
| Free cash flow | -3.1 | 5.8 | -153.4% | -7.2 | 6.9 | -204.3% |
| Other key figures | ||||||
| Capital expenditure | 2.8 | 1.6 | 75.0% | 6.9 | 5.2 | 32.7% |
| Capital expenditure ratio |
12.7% | 5.0% | - | 7.0% | 4.6% | - |
| Depreciation and amortisation |
1.0 | 1.4 | -28.6% | 3.8 | 4.8 | -20.8% |
| Employees as of 09/30 | - | - | - | 732 | 741 | -1.2% |
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++
| 02 | Foreword by the Management Board | |||
|---|---|---|---|---|
| ---- | -- | -- | ---------------------------------- | -- |
+ ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
+++++++++++++++++++++++++++++++++++++++++++++ +++
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
From left to right: Dr. Stefan Schneidewind (Chief Executive Officer)
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
02
+
Michael Knopp (Chief Financial Officer)
+++++++++++++++++++++++++++++
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
In the report for the first half of the year, we noted in our foreword that we were confident we would be able to achieve the targets we had set for ourselves – sales and earnings before interest and taxes (EBIT) that were roughly on a par with those of 2006. After a disappointing third quarter, we will no longer be able to achieve this goal. At the six-month mark, we did indicate, that a repeat performance of the high 2006 profit would be a considerable challenge. It was also clear that the low order entry in the first quarter would have an effect on sales and earnings in the third quarter.We had, however, been hoping for a substantial order entry in excess of EUR 40 million.
We must now acknowledge the fact that our customers, especially in Asia, exercised restraint in placing orders in the third quarter and deferred investment in new machinery to a later date. A EUR 31.3 million order entry is without a doubt disappointing and all the more so when sales totaled a mere EUR 22.3 million, leading to a EUR 4.9 million EBIT loss for the quarter.
In view of this development, we must reduce our forecast for the entire 2007 fiscal year. Instead of EUR 150 million in sales and a 10% EBIT margin, we now anticipate approximately EUR 140 million in sales and an EBIT of between EUR 6 million and EUR 7 million.The sales and earnings figures for the third quarter were due primarily to delays in the final acceptance of delivered machinery with the result that sales could no longer be booked before September 30. The adjustment of our forecast is also due to significantly lower expectations for the fourth quarter. Although we will indeed finish strong, it will not be sufficient for us to achieve our original sales and earnings guidance.
+ ++++++++++++++++++++++++++++++++++++++++++++++++ Foreword + Sales and Earnings + Financial Report
The EUR 72.0 million order backlog as of September 30 makes us optimistic. It will ensure fourth-quarter sales that will enable us to achieve a significantly positive result on both an EBIT basis and after taxes. Moreover, the fourth quarter shows signs of a considerable improvement in new business, the most important indication of which is the high level of new orders in October amounting to at least EUR 22 million. We assume that we will be able to book at least EUR 40 million in new orders in the last three months of 2007.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++
+++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
In summary, the main message is that SUSS MicroTec will continue to earn a profit in a difficult market environment, though not at the previous year's level. This shows that SUSS MicroTec is much more robust than even five years ago. Today, we are in a position not only to survive hard times, but also to continue to set priorities and look to the future. In 2006 and 2007, for instance,we invested heavily in the Substrate Bonder segment.We now have a competitive product range that should ensure further sales growth in this segment. In addition, our research and development budget is being invested in innovations that are of decisive importance for the industry such as three-dimensional chip bonding, or 3D stacking. We aim to lead the field in this area and – in cooperation with our customers – provide mature solutions.
In this endeavor, we are pleased to have the support of two new Supervisory Board members. Our Management Board colleague from April to September of this year, Dr. Stefan Reineck, was appointed to the Supervisory Board on October 1, taking over from Dr. h.c. Horst Görtz. Secondly, Dr. Christoph Schücking stepped down as a Supervisory Board member on July 6, the day of the Shareholders' Meeting. His place was taken by attorney Heinz-Peter Verspay.
We would like to take this opportunity to thank you all for retaining confidence in us in a far from easy year 2007 and for continuing to believe in the success of SUSS MicroTec AG.
+ + + + ++++++++++++++++++++++++++++++++++++++
Garching, November 2007
Dr. Stefan Schneidewind Michael Knopp Chief Executive Officer Chief Financial Officer
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
04
+
SUSS MicroTec Group sales in the first nine months of the current fiscal year totaled EUR 98.7 million, down 13% in comparison to the previous year's EUR 113.5 million. As expected, most of this decline was in the Lithography division (EUR 54.0 million after EUR 67.5 million), whereas sales in other sectors remained relatively stable. Order entry presents a similar picture. In the first three quarters of 2007, it amounted to EUR 95.5 million, 17% less than the previous year, when it totaled EUR 115.0 million.The order backlog as of September 30 was EUR 72.0 million, down 13% in comparison to the previous year's EUR 82.8 million.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
In the nine-month comparison, gross profit margin fell from 46.2% in 2006 to 43.8% in 2007, due primarily to ongoing high pressure on prices by Asian customers in particular. This and failure to achieve our sales forecast weighed down the operating result (EBIT), which fell by 91% from EUR 14.3 million to EUR 1.3 million, equivalent to an EBIT margin of 1.3% after 12.6% in the first nine months of 2006. Earnings after tax fell by 98% in the review period to EUR 0.2 million from EUR 11.3 million.
As a result of the loss in the third quarter and negative free cash flow in the second and third quarters, the net cash position fell by 41% to EUR 8.3 million from EUR 14.1 million.
The main reason for the poor third quarter sales (EUR 22.3 million) were customer acceptance delays in the Test Systems and Substrate Bonder divisions.
Sales in the SUSS MicroTec Group's most important division totaled EUR 54.0 million in the first nine months of 2007, compared with EUR 67.5 million the previous year (-20%). The division result fell in this time period from EUR 15.2 million to EUR 6.0 million and order entry was down from EUR 64.5 million to EUR 51.3 million due to a subdued H1 in advanced packaging. The third quarter brought with it the expected recovery in new business. At EUR 21.3 million, it was 23% compared to the second quarter of 2007 (EUR 17.2 million) and 25% up compared to the previous year (EUR 17.2 million). This improvement was due primarily to Advanced Packaging customers in Asia, a trend that will continue in the fourth quarter and extend to the Micro Electro Mechanical Systems (MEMS) sector. Moreover, the solid order backlog will lead to a significant sales increase in the fourth quarter and thereby contribute toward a much more positive division result for the full year.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
The service initiative launched last year, with a considerably wider range of service and training offerings, has achieved significant successes, such as the conclusion of long-term maintenance agreements with important manufacturing customers in the third quarter. Continuous development of service offerings in this area is a key component in establishing SUSS MicroTec even more strongly among manufacturing customers.
On the products side, Gamma XPress, a new coating and development system designed for wafer bumping and LED production, was launched successfully in the market. Gamma XPress is available in several standardized configurations for the most frequent applications in these areas.They include coating and development processes in gold bumping, rewiring metallization, or mass production of LEDs. As these configurations make it possible to reduce delivery times, Gamma XPress offers a crucial competitive edge. The first Gamma XPress was sold to Rohm und Haas Electronics Materials in Nigata, Japan. SUSS MicroTec received another important gamma production cluster order from HD Microsystems LLC in the United States.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
In September, SUSS MicroTec organized jointly with Surface Technology Systems (STS), a leading provider of plasma etching and coating systems, a MEMS technology road show in Europe at which the two companies presented their top-ranking technologies to support the most important new MEMS processes. STS's know-how in the field of reactive ion etching effectively complemented SUSS MicroTec's experience in lithography and wafer bonding. A seminar entitled Embracing the Future was held in Geneva, Eindhoven, and Copenhagen. Further events in Europe are planned.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
Sales between January and September 2007 amounted to EUR 11.5 million, down 3% compared to the EUR 11.8 million over the same period in 2006. Order entry was EUR 13.1 million, 4% less than the previous year's EUR 13.6 million. The order backlog as of September 30 was EUR 11.4 million, so it seems realistic that this division will increase sales significantly in comparison to 2006. The nine-month result continues to be burdened by investment in R&D, sales, and marketing amounting to EUR -0.9 million.
Order entry in the third quarter was lower than planned as key customers postponed their orders until the fourth quarter. On the products side, SUSS MicroTec was able to include a first 300-millimeter bonder, the CBCSOI300, in its portfolio and thereby succeed in gaining entry to the highly promising silicon-on-insulator series production market. The new substrate bonder generation, the ELAN range, now consists of three bonders, the CB6L, the CB8, and the CBC300SOI. Further product launches are planned so that SUSS MicroTec is well equipped for the highly promising 3D integration market.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
Another success story is the first delivery of a cluster system for series production to a customer in South Korea.
January to September sales in this division totaled EUR 18.9 million after EUR 20.7 million in the previous year. Order entry was almost unchanged this the year at EUR 20.3 million (previous year: EUR 20.8 million).The result for the period was a EUR 0.1 million loss after a profit of EUR 1.9 million in 2006, with the third-quarter result balanced.
The newly developed 300-millimeter ProbeShield device characterization system's market launch at SEMICON West in San Francisco in July marked a milestone on the products side. SUSS MicroTec anticipates strong customer interest in the system because it delivers high-precision measurement of new types of circuits on the smallest structures and at the same time provides optimal support for the operator. The benefits of the new ProbeShield were demonstrated to measurement engineers during a road show in five Asian countries.
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
In addition, new orders were placed primarily in the opto and MEMS applications field, with demand for our Blue Ray and Croy/Vacuum test systems.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
This division includes photomasks and microoptics business along with the holding function and C4NP (Controlled Collapse Chip Connection New Process). Sales in the first nine months of 2007 were unchanged compared to the previous year at EUR 9.5 million, as was the result (EUR -2.8 million). Order entry declined from EUR 9.1 million to EUR 7.9 million.
The Photomasks business was not quite as good as the previous year. From January to September 2007, both order entry and sales fell from EUR 6.9 million in 2006 to EUR 5.0 million. Microoptics in contrast showed an increase in order entry from EUR 2.2 million to EUR 2.9 million and in sales from EUR 2.5 million to EUR 3.0 million.
Foreword + Sales and Earnings + Financial Report
From January to September 2007, sales in North America totaled EUR 32.3 million (2006: EUR 37.0 million), in Europe EUR 31.4 million (2006: EUR 31.6 million), and Asia EUR 35.0 million (2006: EUR 44.9 million). These figures make it clear that the principal reason for this year's sales decline is that our customers in Asia are holding back on investment.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
The order entry situation is similar. In North America (EUR 27.1 million after EUR 32.6 million) and Europe (EUR 33.1 million after EUR 35.6 million), the decline was relatively moderate, while in Asia it was more significant – from EUR 46.8 million to EUR 35.3 million – with order entry stable in Japan and down disproportionately in Taiwan.
The Supervisory Board appointed Michael Knopp as the SUSS MicroTec Group's new Chief Financial Officer, effective August 1, 2007. Before joining SUSS MicroTec, he was the commercial manager of Kemmax GmbH, a chemicals company based in Essen, in charge of the finance, controlling, administration/HR, and IT departments. The German company is a part of the Canadian listed Chemtrade Logistics Group with annual sales of approximately EUR 370 million.
| Management Board | Shares | Optionen |
|---|---|---|
| Dr. Stefan Schneidewind | 13,278 | 150,000 |
| Dr. Stefan Reineck | 600 | 40,000 |
| Michael Knopp | 0 | 30,000 |
| Supervisory Board | Shares | Optionen |
| Dr. Winfried Süss | 1,131,000 | 0 |
| closing associated persons as defined by § 15a WpHG (Securities Trade Act) |
147,443 | 0 |
| Gerhard Rauter | 0 | 0 |
| Peter Heinz | 1,338 | 0 |
| Prof. Dr. Anton Heuberger | 0 | 0 |
| Dr. e. h. Horst Görtz | 17,216 | 0 |
| Heinz-Peter Verspay | 0 | 0 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ +
+
| Continuing | |
|---|---|
| TEUR | 0perations |
| Sales | 20,970 |
| Cost of sales | -12,367 |
| Gross profit | 8,603 |
| Selling costs | -5,899 |
| Research and development costs | -1,663 |
| Administration costs | -5,326 |
| Other operating income | 398 |
| Other operating expenses | -1,486 |
| Analysis of net income from operations (EBIT): | |
| EBITDA (Earnings before Interest and Taxes, | |
| Depreciation and Amortization) | -4,361 |
| Depreciation and amortization of tangible assets, | |
| intangible assets and investments in subsidiaries | -1,012 |
| Net income from operations (EBIT) | -5,373 |
| Interest expenses | -68 |
| Interest income | 129 |
| Income before taxes | -5,312 |
| Income taxes | -282 |
| Net profit or loss | -5,594 |
| Thereof minority interests | 40 |
| Thereof equity holders of SUSS MicroTec | -5,634 |
| Earnings per share | |
| Basic earnings per share in EUR | -0.33 |
| Diluted earnings per share in EUR | -0.33 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
10
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | Foreword + |
+ | + | + + |
+ | + | Sales and Earnings + |
+ | + | + | + | + | + | + | + | + + |
+ | + | + | + + |
Financial Report + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + |
+ +++++++++++++++++++++++++++++++++++++++++++++++
| 07/01/ – 09/30/2007 | 07/01/ – 09/30/2006 | |||
|---|---|---|---|---|
| Discontinued | Continuing | Discontinued | ||
| 0perations | Group | 0perations | 0perations | Group |
| 1,316 | 22,286 | 30,131 | 1,209 | 31,340 |
| -689 | -13,056 | -16,630 | -698 | -17,328 |
| 627 | 9,230 | 13,501 | 511 | 14,012 |
| -121 | -6,020 | -5,088 | -314 | -5,402 |
| -12 | -1,675 | -1,360 | 181 | -1,179 |
| 19 | -5,307 | -5,271 | -126 | -5,397 |
| 1 | 399 | 603 | 2 | 605 |
| -4 | -1,490 | -938 | 0 | -938 |
| 510 | -3,851 | 2,798 | 328 | 3,126 |
| 0 | -1,012 | -1,351 | -74 | -1,425 |
| 510 | -4,863 | 1,447 | 254 | 1,701 |
| -30 | -98 | -154 | 0 | -154 |
| 13 | 142 | 108 | 0 | 108 |
| 493 | -4,819 | 1,401 | 254 | 1,655 |
| -164 | -446 | -220 | -85 | -305 |
| 329 | -5,265 | 1,181 | 169 | 1,350 |
| 0 | 40 | 52 | 0 | 52 |
| 329 | -5,305 | 1,129 | 169 | 1,298 |
| 0.02 | -0.31 | 0.07 | 0.01 | 0.08 |
| 0.02 | -0.31 | 0.07 | 0.01 | 0.08 |
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
12
+
| Continuing | |
|---|---|
| TEUR | 0perations |
| Sales | 93,848 |
| Cost of sales | -52,933 |
| Gross profit | 40,915 |
| Selling costs | -18,009 |
| Research and development costs | -5,098 |
| Administration costs | -15,863 |
| Other operating income | 923 |
| Other operating expenses | -2,326 |
| Analysis of net income from operations (EBIT): | |
| EBITDA (Earnings before Interest and Taxes, | |
| Depreciation and Amortization) | 4,280 |
| Depreciation and amortization of tangible assets, | |
| intangible assets and investments in subsidiaries | -3,738 |
| Net income from operations (EBIT) | 542 |
| Interest expenses | -235 |
| Interest income | 394 |
| Income before taxes | 701 |
| Income taxes | -872 |
| Net profit or loss | -171 |
| Thereof minority interests | 188 |
| -359 | |
| Thereof equity holders of SUSS MicroTec | |
| Earnings per share | |
| -0.01 | |
| Basic earnings per share in EUR | |
| Diluted earnings per share in EUR | -0.01 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | Foreword + |
+ | + | + | + | + + |
+ | + | Sales and Earnings + |
+ | + | + | + | + | + | + | + | + + + |
+ | + | Financial Report + |
+ | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + + |
+ | + |
+ +++++++++++++++++++++++++++++++++++++++++++++++
| 01/01/ – 09/30/2007 | 01/01/ – 09/30/2006 | |||
|---|---|---|---|---|
| Discontinued | Continuing | Discontinued | ||
| 0perations | Group | 0perations | 0perations | Group |
| 4,803 | 98,651 | 109,439 | 4,019 | 113,458 |
| -2,501 | -55,434 | -59,335 | -1,656 | -60,991 |
| 2,302 | 43,217 | 50,104 | 2,363 | 52,467 |
| -1,122 | -19,131 | -16,137 | -1,180 | -17,317 |
| -153 | -5,251 | -4,714 | -69 | -4,783 |
| -299 | -16,162 | -14,717 | -450 | -15,167 |
| 0 | 923 | 1,431 | 60 | 1,491 |
| -13 | -2,339 | -2,416 | 0 | -2,416 |
| 797 | 5,077 | 18,167 | 894 | 19,061 |
| -82 | -3,820 | -4,616 | -170 | -4,786 |
| 715 | 1,257 | 13,551 | 724 | 14,275 |
| -121 | -356 | -712 | 0 | -712 |
| 28 | 422 | 348 | 0 | 348 |
| 622 | 1,323 | 13,187 | 724 | 13,911 |
| -207 | -1,079 | -2,360 | -241 | -2,601 |
| 415 | 244 | 10,827 | 483 | 11,310 |
| 0 | 188 | 94 | 0 | 94 |
| 415 | 56 | 10,733 | 483 | 11,216 |
| 0.02 | 0.01 | 0.64 | 0.03 | 0.67 |
| 0.62 | 0.03 | 0.65 | ||
| 0.02 | 0.01 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
| TEUR | ||
|---|---|---|
| ASSETS | 09/30/2007 | 12/31/2006 |
| Non-current assets | 53,555 | 52,435 |
| Intangible assets | 16,944 | 14,514 |
| Goodwill | 22,206 | 22,726 |
| Tangible assets | 4,529 | 4,948 |
| Other investments | 5 | 5 |
| Tax assets | 598 | 598 |
| Other assets | 386 | 417 |
| Deferred tax assets | 8,887 | 9,227 |
| Current assets | 92,074 | 104,840 |
| Inventories | 58,571 | 57,964 |
| Accounts receivable | 15,016 | 23,244 |
| Securities | 4 | 9 |
| Tax assets | 1,715 | 1,265 |
| Cash and cash equivalents | 11,288 | 20,459 |
| Other assets | 5,480 | 1,899 |
| Balance sheet total | 145,629 | 157,275 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + +
| TEUR | ||
|---|---|---|
| LIABILITIES & SHAREHOLDERS' EQUITY | 09/30/2007 | 12/31/2006 |
| Shareholders' equity | 99,101 | 99,155 |
| Subscribed capital | 17,019 | 17,007 |
| Reserves | 82,857 | 82,339 |
| Accumulated other comprehensive income | -1,126 | -354 |
| Minority interests | 351 | 163 |
| Non-current liabilities | 10,011 | 11,787 |
| Pension provisions | 2,592 | 2,596 |
| Other provisions | 515 | 586 |
| Financial debt | 817 | 2,677 |
| Other liabilities | 70 | 195 |
| Deferred tax liabilities | 6,017 | 5,733 |
| Current liabilities | 36,517 | 46,333 |
| Other provisions | 3,029 | 5,030 |
| Tax liabilities | 1,254 | 1,338 |
| Financial debt | 2,177 | 3,116 |
| Accounts payable | 5,955 | 6,418 |
| Other liabilities | 24,102 | 30,431 |
| Balance sheet total | 145,629 | 157,275 |
+ + + + ++++++++++++++++++++++++++++++++++++++
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
16
+
| TEUR | 01/01/ – 09/30/2007 |
01/01/ – 09/30/2006 |
|---|---|---|
| Net profit or loss | 244 | 11,310 |
| Amortization of intangible assets | 2,621 | 3,023 |
| Depreciation of tangible assets | 1,199 | 1,763 |
| Profit or loss on disposal of intangible and tangible assets |
78 | 2 |
| Profit or loss on disposal of assets and liabilities from discontinued operations |
-103 | 0 |
| Change of reserves on inventories | 1,883 | 1,619 |
| Change of reserves for bad debts | -351 | 391 |
| Non-cash stock based compensation | 442 | 263 |
| Non-cash income from the reversal of provisions | -174 | -199 |
| Non-cash interest expenses from increase of convertible debt |
14 | 81 |
| Other non-cash effective income and expenses | 2,349 | 1,686 |
| Change in inventories | -9,074 | -14,031 |
| Change in accounts receivable | 6,611 | 5,993 |
| Change in other assets | -776 | -713 |
| Change in pension provisions | 36 | 89 |
| Change in accounts payable | 619 | 909 |
| Change in other liabilities and other provisions | -7,480 | 24 |
| Change of deferred taxes | 624 | -114 |
| Cash Flow from operating activities | -1,238 | 12,096 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| + | + | + | + | + | + | + | + | + + |
+ | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | + | + | + | + | + | + | + | + + |
+ | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + + |
+ | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | Foreword + |
+ | + | + + |
+ | + + |
+ | + + |
+ | + | Sales and Earnings + |
+ | + | + | + | + | + + |
+ | Financial Report + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + + |
+ + |
+ | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
+ +++++++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++ +++ +
| TEUR | 01/01/ – 09/30/2007 |
01/01/ – 09/30/2006 |
|---|---|---|
| Payments in tangible assets | -1,597 | -1,668 |
| Payments in intangible assets | -5,346 | -3,508 |
| Proceeds from disposal of intangible and tangible assets |
6 | 0 |
| Proceeds from disposal of non-current assets held for sale |
1,000 | 0 |
| Cash Flow from investing activities | -5,937 | -5,176 |
| Increase of bank loans | 0 | 478 |
| Repayment of bank loans | -1,786 | -7,150 |
| Repayment of convertible bond | 0 | -3,622 |
| Change of current bank liabilities | 296 | -1,691 |
| Change in other financial debt | -127 | -54 |
| Proceeds from issuance of common stocks | 32 | 12 |
| Cash Flow from financing activities | -1,585 | -12,027 |
| Adjustments to funds caused by | ||
| exchange-rate fluctuations | -411 | -326 |
| Change in cash and cash equivalents | -9,171 | -5,433 |
| Funds at beginning of the year | 20,459 | 26,325 |
| Funds at end of the period | 11,288 | 20,892 |
| Cash flow from operating activities includes: | ||
| Interest paid during the period | 342 | 579 |
| Interest received during period | 422 | 348 |
| Tax paid during the period | 873 | 894 |
| Tax refunds during the period | 402 | 35 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
| Number of shares |
Common | Additional paid-in |
||
|---|---|---|---|---|
| TEUR | (in thousands) | stock | capital | |
| As of January 01, 2006 | 16,793 | 16,793 | 90,673 | |
| Issuance of shares: Exercise of stock options |
11 | 11 | 1 | |
| Issuance of subscription rights | 263 | |||
| Net profit loss or loss | ||||
| Unrealized loss from securities net of tax |
||||
| Foreign currency adjustment | ||||
| As of September 30, 2006 | 16,804 | 16,804 | 90,937 | |
| As of January 01, 2007 | 17,007 | 17,007 | 91,573 | |
| Issuance of shares: Exercise of stock options |
12 | 12 | 20 | |
| Issuance of subscription rights | 442 | |||
| Net profit loss or loss | ||||
| Unrealized loss from securities net of tax |
||||
| Foreign currency adjustment | ||||
| As of September 30, 2007 | 17,019 | 17,019 | 92,035 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
| + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + Foreword Sales and Earnings Financial Report + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + |
+ | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + |
| Earnings | Retained | Accumulated other Com prehensive |
Minority | |
|---|---|---|---|---|
| reserve | Earnings | Income | interests | Total |
| 433 | -24,466 | 683 | 49 | 84,165 |
| 12 | ||||
| 263 | ||||
| 11,216 | 94 | 11,310 | ||
| -24 | -24 | |||
| -644 | -644 | |||
| 433 | -13,250 | 15 | 143 | 95,082 |
| 433 | -9,667 | -354 | 163 | 99,155 |
| 32 | ||||
| 442 | ||||
| 56 | 188 | 244 | ||
| -6 | -6 | |||
| -766 | -766 | |||
| 433 | -9,611 | -1,126 | 351 | 99,101 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
| 9M/2007 | 9M/2006 | 9M/2007 | 9M/2006 | |
|---|---|---|---|---|
| 53,961 | 67,544 | 11,524 | 11,787 | |
| 5,971 | 15,158 | -868 | 192 | |
| -1,202 | -1,417 | -271 | -54 | |
| 59,010 | 64,416 | 21,334 | 17,467 | |
| 13,599 | 13,599 | 0 | 0 | |
| -16,984 | -24,853 | -4,839 | -3,815 | |
| 2,391 | 2,459 | 790 | 808 | |
| 2,391 | 2,299 | 790 | 808 | |
| 0 | 160 | 0 | 0 | |
| 1,525 | 1,408 | 2,952 | 925 | |
| 311 | 299 | 98 | 89 | |
| Lithography | Substrate Bonder |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| Sales | Capital expenditure | ||||
|---|---|---|---|---|---|
| TEUR | 9M/2007 | 9M/2006 | 9M/2007 | 9M/2006 | |
| Europe | 31,403 | 31,367 | 3,411 | 3,042 | |
| North-America | 32,234 | 37,029 | 3,270 | 1,888 | |
| Japan | 10,370 | 11,066 | 195 | 49 | |
| Rest of asia | 24,616 | 33,717 | 67 | 51 | |
| Rest of world | 28 | 279 | 0 | 146 | |
| Consolidation effects | 0 | 0 | 0 | 0 | |
| Total | 98,651 | 113,458 | 6,943 | 5,176 |
20
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | Foreword + |
+ | + | + | + | + + |
+ | + | + | + | Sales and Earnings + |
+ | + | + | + | + | + | + + |
+ | + | + | Financial Report + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
+ +++++++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++ +++ +
| Device Bonder | Test systems | Other | Total | ||||
|---|---|---|---|---|---|---|---|
| 9M/2007 | 9M/2006 | 9M/2007 | 9M/2006 | 9M/2007 | 9M/2006 | 9M/2007 | 9M/2006 |
| 4,803 | 4,019 | 18,929 | 20,714 | 9,434 | 9,394 | 98,651 | 113,458 |
| 715 | 724 | -127 | 1,911 | -2,837 | -2,799 | 2,854 | 15,186 |
| 173 | -461 | -71 | 43 | -429 | -185 | -1,800 | -2,074 |
| 1,164 | 7,340 | 16,422 | 16,981 | 19,460 | 16,597 | 117,390 | 122,801 |
| 0 | 0 | 4,143 | 4,416 | 4,464 | 5,008 | 22,206 | 23,023 |
| -2,184 | -3,032 | -3,261 | -4,627 | -4,115 | -4,165 | -31,383 | -40,492 |
| 6 | 140 | 247 | 235 | 386 | 1,144 | 3,820 | 4,786 |
| 6 | 140 | 247 | 235 | 386 | 1,144 | 3,820 | 4,626 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 160 |
| 9 | 39 | 280 | 177 | 2,177 | 2,627 | 6,943 | 5,176 |
| 36 | 45 | 138 | 130 | 177 | 178 | 760 | 741 |
| Assets | ||
|---|---|---|
| 9M/2007 | 9M/2006 |
|---|---|
| 72,027 | 76,851 |
| 40,957 | 43,064 |
| 4,610 | 6,106 |
| 625 | 630 |
| 2,724 | 3,666 |
| -3,553 | -7,516 |
| 117,390 | 122,801 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
The consolidated financial statements of SUSS MicroTec AG as of December 31, 2006 were prepared in accordance with International Financial Reporting Standards (IFRSs) issued by the International Accounting Standards Board (IASB) and valid as of the balance sheet date. The interim Group financial statements as of September 30, 2007, which have been prepared in accordance with International Accounting Standard (IAS) 34 "Interim Financial Reporting", have been drawn up using the same accounting methods as in the 2006 Group financial statements.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
All interpretations of the International Financial Reporting Interpretations Committee (IFRIC), which are mandatory as of September 30, 2007 have also been applied.
For additional information on the individual accounting methods applied, please refer to the consolidated financial statements of SUSS MicroTec AG as of December 31, 2006.
SUSS MicroTec AG applies IFRS7 "Financial Instruments: Disclosures" since January 1, 2007. The application of the standard has no impact on the assets, financial position and result of operations net of SUSS MicroTec, but will lead to more extensive disclosures on financial instruments in the Group financial statements for the year ended December 31, 2007.
The interim financial statements were neither audited by the group's auditors, KPMG Deutsche Treuhand-Gesellschaft, Aktiengesellschaft, Wirtschaftsprüfungsgesellschaft, nor did they undergo an auditing review.
All amounts are indicated in thousands of euros (TEUR) unless otherwise noted.
The financial statements of SUSS MicroTec AG and all of the major companies for which there is a group control option according to the control principle, irrespective of the level of participating interest, are included in the consolidated financial statements.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
In the third quarter, SUSS MicroTec AG sold off its inactive interest in SUSS MicroTec Laboratory Equipment GmbH to SUSS MicroTec Lithography GmbH. Subsequently, SUSS MicroTec Laboratory Equipment GmbH was merged with SUSS MicroTec Lithography GmbH. This change in the Group structure has no impact on the result of operations, financial position and net assets of the Group.
Apart from that, no changes of Group structure occured within the third quarter.
By the terms of a purchase contract dated July 16, 2007, SUSS MicroTec AG sold its business with Device Bonders. SUSS MicroTec S.A.S., located in St. Jeoire, France, a wholly owned subsidiary of the holding company, agreed with the management of SMT S.A.S. to sell the Device Bonder business to a company held by the management of SMT S.A.S. under a management buyout (MBO).
Under an asset deal, all material assets and liabilities of SMT S.A.S. belonging to the Device Bonder business were sold. The transfer of the device bonder business took place with economic effect from January 1, 2007.The purchase price is EUR 2.0 million and corresponds approximately to the difference between the assets transferred and the liabilities assumed by the purchaser as of January 1, 2007. In addition, all cash-effective changes of transferred assets and assumed liabilities in the period form January 1, 2007 until closing day will be compensated by a cash settlement between contractual partners. From a group perspective, SMT Group realized a gain of EUR 0,1 million out of the disposal of Device Bonder related assets and liabilities.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
The Consolidated Statement of Cash Flows contains the following components relating to discontinued operations:
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| Discontinued operations | ||
|---|---|---|
| 01/01/-09/30/ | 01/01/-09/30/ | |
| in TEUR | 2007 | 2006 |
| Cash flow from operating activities | -1,516 | 1,804 |
| Cash flow from investing activities | -25 | -23 |
| Cash flow from financing activities | -146 | -441 |
The increase of other current assets as of September 30, 2007 mainly derives from residual parts of the purchase price for the Device Bonder business in an amount of EUR 2.8 million.
There were no further circumstances during the interim reporting period which had any impact on the assets, liabilities, shareholders' equity, period results or cash flow and which were unusual due to their type, extent or frequency.
If estimates were made within the scope of the interim reporting, they shall remain essentially unchanged in methodology within the fiscal year and in the fiscal year comparison.
In contrast to the method of approach at year-end, the income tax expense in each interim reporting period is recorded on the basis of the best estimate of the weighted average annual income tax rate expected for the entire fiscal year.
As a result of valuation allowances made to capitalized loss carry-forwards in the past, SUSS MicroTec AG is presently assuming an annual income tax rate that will be considerably lower than the expected income tax rate of 37%. Following the corporate tax reform act 2008, which was passed by
+
the German Federal Council (upper house of parliament) on July 6, 2007, tax rates in Germany will be considerably reduced.Thus, estimated tax rate for SUSS MicroTec AG and its German subsidiaries will amount to approximately 28% from the beginning of financial year 2008. This made a revaluation of the Group's tax position necessary. Due to the backlog of deferred tax assets in Germany the SUSS MicroTec Group faced an additional, non cash-effective expense of EUR 0.9 million in the third quarter.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
Furthermore, there were no changes subject to reporting requirements that have a significant impact on the current interim reporting period.
No issues, buybacks or repayments were effected during the reporting period, either for debenture bonds or for other equity securities.
No dividends were paid out or proposed for disbursement during the reporting period.
There were no significant events subject to reporting requirements after the close of the interim reporting period.
There are no contingent claims. There were no significant changes in contingent liabilities with respect to the reporting time frame of December 31, 2006.
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
The undiluted earnings per share are determined by dividing the net income for the period accruing to the shares (after minority interests) by the average number of shares.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
To determine the diluted earnings per share, the profit for the period to be attributed to the shareholders (after minority interests), as well as the weighted average of the shares in circulation, must be adjusted for the effects of all potentially diluting shares.
| November,14 | Shareholders' Equity Forum of the German Stock Exchange, Frankfurt a. M./Germany |
|---|---|
| December, 05-07 | SEMICON Japan, Chiba |
Forward-looking statements: The reports contain forward-looking statements. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates and projections, and you should not place too much reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update any of them in light of new information or future events. Forward-looking statements involve inherent risks and uncertainties. We caution you that a number of important factors could cause actual results or outcomes to differ materially from those expressed in any forwardlooking statement.
| Published by: | SUSS MicroTec AG |
|---|---|
| Edited by: | Investor Relations, Group Accounting & Financial Reporting |
| Concept and design: | IR-One AG & Co., Hamburg |
| Printer: | Hartung Druck + Medien GmbH, Hamburg |
| Translation: | EnglishBusiness GbR, Hamburg |
Foreword + Sales and Earnings + Financial Report
+ + + + ++++++++++++++++++++++++++++++++++++++
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
SUSS MicroTec AG Schleißheimer Strasse 90 85748 Garching, Germany Phone: +49 (0)89-32007-0 E-mail: [email protected]
Investor Relations Phone: +49 (0)89-32007-454 E-mail: [email protected]
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
+ + + + ++++++++++++++++++++++++++++++++++++++ + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.